Matching articles for "Palladone"
Issue 1214 · August 1, 2005 Free
In Brief: Palladone Withdrawn

The Medical Letter review of Palladone (hydromorphone HCl) extended-release capsules (March 14, 2005) warned that a lethal dose could be released if the new formulation was taken with alcohol. Because of that…

Med Lett Drugs Ther. 2005 Aug 1; 47(1214):61
The Medical Letter review of Palladone (hydromorphone HCl) extended-release capsules (March 14, 2005) warned that a lethal dose could be released if the new formulation was taken with alcohol. Because of that risk, the FDA asked the manufacturer (Purdue) to withdraw the drug from the market (FDA News. July 13, 2005; FDC Reports – “The Pink Sheet” July 18, 2005; 67:3) .
Issue 1204 · March 14, 2005
Palladone for Chronic Pain

A once-daily extended-release (ER) oral formulation of the opioid analgesic hydromorphone hydrochloride ( Palladone - Purdue Pharma) has been approved by the FDA for treatment of opioid-tolerant patients with…

Med Lett Drugs Ther. 2005 Mar 14; 47(1204):21-3
A once-daily extended-release (ER) oral formulation of the opioid analgesic hydromorphone hydrochloride ( Palladone - Purdue Pharma) has been approved by the FDA for treatment of opioid-tolerant patients with persistent moderate to severe pain. Hydromorphone HCl, a semisynthetic congener of morphine and active metabolite of hydrocodone that has been used since the 1920s, is also available in immediate-release oral, injectable and suppository forms ( Dilaudid , and others).